GEN-1044

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameGEN-1044
Drug Alias NameGEN-1044
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-CD3Trophoblast glycoprotein modulators
TargetsT cell surface glycoprotein CD3Trophoblast glycoprotein
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsProstatic Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmarkIsrael +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenmab A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenmab A/SAbbvie Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursUrinary Bladder NeoplasmsProstatic Neoplasms +[8] 

Other Information

ATC CodeN/A
Related LinksN/A